- Home
- VRDN vs HSAI Comparison
VRDN vs HSAI Comparison
Compare VRDN & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRDN | HSAI |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | China |
| Employees | 252 | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VRDN | HSAI |
|---|---|---|
| Price | $18.59 | $16.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | ★ $36.75 | $28.49 |
| AVG Volume (30 Days) | ★ 1.7M | 885.1K |
| Earning Date | 11-04-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | N/A | $41.85 |
| Revenue Next Year | $681.16 | $41.74 |
| P/E Ratio | ★ N/A | $61.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.18 | $14.29 |
| 52 Week High | $34.29 | $29.35 |
Technical Indicators
Market Signals| Indicator | VRDN | HSAI |
|---|---|---|
| Relative Strength Index (RSI) | 33.99 | 46.02 |
| Support Level | $17.97 | $15.81 |
| Resistance Level | $20.33 | $19.29 |
| Average True Range (ATR) | 0.84 | 0.40 |
| MACD | -0.23 | 0.01 |
| Stochastic Oscillator | 20.46 | 34.31 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About HSAI Hesai Group each ADS represents one Class B ordinary share
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.